Search Results

There are 7720 results for: content related to: Screening for LRRK2 mutations in patients with Parkinson’s disease in Russia: identification of a novel LRRK2 variant

  1. You have free access to this content
    Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER–Golgi export

    The EMBO Journal

    Volume 33, Issue 20, 16 October 2014, Pages: 2314–2331, Hyun Jin Cho, Jia Yu, Chengsong Xie, Parvathi Rudrabhatla, Xi Chen, Junbing Wu, Loukia Parisiadou, Guoxiang Liu, Lixin Sun, Bo Ma, Jinhui Ding, Zhihua Liu and Huaibin Cai

    Version of Record online : 8 SEP 2014, DOI: 10.15252/embj.201487807

  2. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2536–2541, Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius and Susan B. Bressman

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23314

  3. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe

    Human Mutation

    Volume 33, Issue 7, July 2012, Pages: 1087–1098, Justin P. Rubio, Simon Topp, Liling Warren, Pamela L. St. Jean, Daniel Wegmann, Darren Kessner, John Novembre, Judong Shen, Dana Fraser, Jennifer Aponte, Keith Nangle, Lon R. Cardon, Margaret G. Ehm, Stephanie L. Chissoe, John C. Whittaker, Matthew R. Nelson and Vincent E. Mooser

    Version of Record online : 4 APR 2012, DOI: 10.1002/humu.22075

  4. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1192–1202, Connie Marras, Roy N. Alcalay, Chelsea Caspell-Garcia, Christopher Coffey, Piu Chan, John E. Duda, Maurizio F. Facheris, Rubén Fernández-Santiago, Javier Ruíz-Martínez, Tiago Mestre, Rachel Saunders-Pullman, Claustre Pont-Sunyer, Eduardo Tolosa, Bjorg Waro and the LRRK2 Cohort Consortium

    Version of Record online : 19 APR 2016, DOI: 10.1002/mds.26614

  5. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 906–914, Dolores Vilas, Leslie M. Shaw, Peggy Taylor, Daniela Berg, Kathrin Brockmann, Jan Aasly, Connie Marras, Claustre Pont-Sunyer, José Ríos, Ken Marek and Eduardo Tolosa

    Version of Record online : 4 APR 2016, DOI: 10.1002/mds.26591

  6. You have free access to this content
    Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 650–658, Jingwen Niu, Mei Yu, Chunyan Wang and Zhiheng Xu

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07809.x

  7. You have full text access to this OnlineOpen article
    Novel recruitment strategy to enrich for LRRK2 mutation carriers

    Molecular Genetics & Genomic Medicine

    Volume 3, Issue 5, September 2015, Pages: 404–412, Tatiana Foroud, Danielle Smith, Jacqueline Jackson, Jennifer Verbrugge, Cheryl Halter, Leah Wetherill, Katherine Sims, Winnie Xin, Vanessa Arnedo, Shirley Lasch, Kenneth Marek and the Parkinson's Progression Markers Initiative

    Version of Record online : 6 MAY 2015, DOI: 10.1002/mgg3.151

  8. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

    Movement Disorders

    Volume 27, Issue 1, January 2012, Pages: 146–150, Oswaldo Lorenzo-Betancor, Lluís Samaranch, Mario Ezquerra, Eduardo Tolosa, Elena Lorenzo, Jaione Irigoyen, Carles Gaig, María A. Pastor, Alexandra I. Soto-Ortolaza, Owen A. Ross, María C. Rodríguez-Oroz, Francesc Valldeoriola, María J. Martí, María R. Luquin, Jordi Perez-Tur, Juan A. Burguera, José A. Obeso and Pau Pastor

    Version of Record online : 28 OCT 2011, DOI: 10.1002/mds.23968

  9. You have free access to this content
    Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration

    Movement Disorders

    Volume 32, Issue 1, January 2017, Pages: 115–123, Monica Sanchez-Contreras, Michael G. Heckman, Pawel Tacik, Nancy Diehl, Patricia H. Brown, Alexandra I. Soto-Ortolaza, Elizabeth A. Christopher, Ronald L. Walton, Owen A. Ross, Lawrence I. Golbe, Neill Graff-Radford, Zbigniew K. Wszolek, Dennis W. Dickson and Rosa Rademakers

    Version of Record online : 6 OCT 2016, DOI: 10.1002/mds.26815

  10. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 889–897, Nicolas Dzamko, Dominic B. Rowe and Glenda M. Halliday

    Version of Record online : 25 FEB 2016, DOI: 10.1002/mds.26529

  11. Cognitive profile of LRRK2-related Parkinson's disease

    Movement Disorders

    Volume 30, Issue 5, 15 April 2015, Pages: 728–733, Sindhu Srivatsal, Brenna Cholerton, James B. Leverenz, Zbigniew K. Wszolek, Ryan J. Uitti, Dennis W. Dickson, Daniel Weintraub, John Q. Trojanowski, Vivianna M. Van Deerlin, Joseph F. Quinn, Kathryn A. Chung, Amie L. Peterson, Stewart A. Factor, Cathy Wood-Siverio, Jennifer G. Goldman, Glenn T. Stebbins, Bryan Bernard, Beate Ritz, Rebecca Rausch, Alberto J. Espay, Fredy J. Revilla, Johnna Devoto, Liana S. Rosenthal, Ted M. Dawson, Marilyn S. Albert, Ignacio F. Mata, Shu-Ching Hu, Kathleen S. Montine, Catherine Johnson, Thomas J. Montine, Karen L. Edwards, Jing Zhang and Cyrus P. Zabetian

    Version of Record online : 4 FEB 2015, DOI: 10.1002/mds.26161

  12. Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with l-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesia

    European Journal of Neuroscience

    Volume 26, Issue 1, July 2007, Pages: 171–177, M. J. Hurley, P. H. Patel, M. J. Jackson, L. A. Smith, S. Rose and P. Jenner

    Version of Record online : 3 JUL 2007, DOI: 10.1111/j.1460-9568.2007.05638.x

  13. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1004–1011, David A. Elliott, Woojin S. Kim, Sarsha Gorissen, Glenda M. Halliday and John B.J. Kwok

    Version of Record online : 23 APR 2012, DOI: 10.1002/mds.25005

  14. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia

    European Journal of Neurology

    Volume 14, Issue 4, April 2007, Pages: 413–417, S. N. Illarioshkin, M. I. Shadrina, P. A. Slominsky, E. V. Bespalova, T. B. Zagorovskaya, G. Kh. Bagyeva, E. D. Markova, S. A. Limborska and I. A. Ivanova-Smolenskaya

    Version of Record online : 23 MAR 2007, DOI: 10.1111/j.1468-1331.2007.01685.x

  15. LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain

    European Journal of Neuroscience

    Volume 23, Issue 3, February 2006, Pages: 659–666, Javier Simón-Sánchez, Vicente Herranz-Pérez, Francisco Olucha-Bordonau and Jordi Pérez-Tur

    Version of Record online : 16 FEB 2006, DOI: 10.1111/j.1460-9568.2006.04616.x

  16. Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study

    Movement Disorders

    Volume 31, Issue 12, December 2016, Pages: 1820–1828, Dolores Vilas, Bàrbara Segura, Hugo C. Baggio, Claustre Pont-Sunyer, Yaroslau Compta, Francesc Valldeoriola, María José Martí, María Quintana, Angels Bayés, Jorge Hernández-Vara, Matilde Calopa, Miquel Aguilar, Carme Junqué, Eduardo Tolosa and and the Barcelona LRRK2 Study Group

    Version of Record online : 21 SEP 2016, DOI: 10.1002/mds.26799

  17. You have free access to this content
    Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis

    Journal of Bone and Mineral Research

    Volume 28, Issue 9, September 2013, Pages: 1962–1974, Weirong Xing, Jeff Liu, Shaohong Cheng, Peter Vogel, Subburaman Mohan and Robert Brommage

    Version of Record online : 19 AUG 2013, DOI: 10.1002/jbmr.1935

  18. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain

    European Journal of Neurology

    Volume 16, Issue 8, August 2009, Pages: 957–960, L. Gao, P. Gómez-Garre, F. J. Díaz-Corrales, F. Carrillo, M. Carballo, A. Palomino, J. Díaz-Martín, R. Mejías, P. J. Vime, J. López-Barneo and P. Mir

    Version of Record online : 31 MAR 2009, DOI: 10.1111/j.1468-1331.2009.02620.x

  19. Low-variance RNAs identify Parkinson's disease molecular signature in blood

    Movement Disorders

    Volume 30, Issue 6, May 2015, Pages: 813–821, Maria D. Chikina, Christophe P. Gerald, Xianting Li, Yongchao Ge, Hanna Pincas, Venugopalan D. Nair, Aaron K. Wong, Arjun Krishnan, Olga G. Troyanskaya, Deborah Raymond, Rachel Saunders-Pullman, Susan B. Bressman, Zhenyu Yue and Stuart C. Sealfon

    Version of Record online : 18 MAR 2015, DOI: 10.1002/mds.26205

  20. You have free access to this content
    LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles

    The FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6445–6454, Zhenyu Yue

    Version of Record online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07343.x